Summit Therapeutics Inc. Number of Operating Segments
Summit Therapeutics Inc. (SMMT) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-07-23
- Summit Therapeutics Inc. number of operating segments for the quarter ending 2026-03-31 was 1.00 segment.
- Summit Therapeutics Inc. number of operating segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Summit Therapeutics Inc. number of operating segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Summit Therapeutics Inc. number of operating segments for the quarter ending 2022-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Summit Therapeutics Inc. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- Summit Therapeutics Inc. number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- Summit Therapeutics Inc. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- Summit Therapeutics Inc. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-07-23 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-23 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-20 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-11 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-24 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-10-30 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-01 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-20 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-09 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | 1.00 segment 10-K/A · filed 2022-12-21 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-17 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |